Health benefits that have resulted from reductions in fine particulate air pollution aren’t distributed equally among populations in the U.S., a new Yale-led study finds.
iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer – Biotech Investments
EQS-News: iOmx Therapeutics AG / Key word(s): Personnel iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CEST The issuer